SLI
|
2 101,98
|
7,24
|
0,35 %
|
Analysen zu SLI-Werten
| 14:58 | Nestlé Neutral | JP Morgan Chase & Co. | |
| 08:37 | Swiss Re Underperform | RBC Capital Markets | |
| 08:31 | Zurich Insurance Underweight | JP Morgan Chase & Co. | |
| 08:28 | Swiss Re Neutral | JP Morgan Chase & Co. | |
| 07:16 | Roche Neutral | JP Morgan Chase & Co. | |
| 07:14 | Novartis Overweight | JP Morgan Chase & Co. | |
| 05.12.25 | Swiss Re Underweight | Barclays Capital | |
| 05.12.25 | Zurich Insurance Hold | Jefferies & Company Inc. | |
| 05.12.25 | Swiss Re Hold | Jefferies & Company Inc. | |
| 05.12.25 | Swiss Re Neutral | Goldman Sachs Group Inc. | |
| 05.12.25 | UBS Outperform | RBC Capital Markets | |
| 05.12.25 | Roche Buy | UBS AG | |
| 05.12.25 | Swiss Re Hold | Jefferies & Company Inc. | |
| 05.12.25 | Swiss Re Underperform | RBC Capital Markets | |
| 04.12.25 | Givaudan Neutral | JP Morgan Chase & Co. | |
| 04.12.25 | UBS Buy | Goldman Sachs Group Inc. | |
| 04.12.25 | ABB Neutral | JP Morgan Chase & Co. | |
| 02.12.25 | Zurich Insurance Buy | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 02.12.25 | UBS Overweight | JP Morgan Chase & Co. | |
| 01.12.25 | Richemont Buy | Deutsche Bank AG | |
| 01.12.25 | Swiss Re Underperform | RBC Capital Markets | |
| 01.12.25 | Roche Hold | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 01.12.25 | ams-OSRAM Underweight | JP Morgan Chase & Co. | |
| 28.11.25 | Richemont Overweight | JP Morgan Chase & Co. | |
| 27.11.25 | Richemont Buy | UBS AG | |
| 26.11.25 | ams-OSRAM Buy | Deutsche Bank AG | |
| 26.11.25 | Nestlé Neutral | JP Morgan Chase & Co. | |
| 26.11.25 | Givaudan Neutral | JP Morgan Chase & Co. | |
| 25.11.25 | Nestlé Market-Perform | Bernstein Research | |
| 25.11.25 | UBS Underweight | Barclays Capital | |
| 24.11.25 | ABB Hold | Jefferies & Company Inc. | |
| 24.11.25 | Givaudan Buy | Deutsche Bank AG | |
| 21.11.25 | Novartis Neutral | UBS AG | |
| 21.11.25 | Novartis Buy | Deutsche Bank AG | |
| 21.11.25 | Novartis Underweight | Barclays Capital | |
| 21.11.25 | Novartis Outperform | Bernstein Research | |
| 21.11.25 | ams-OSRAM Hold | Jefferies & Company Inc. | |
| 20.11.25 | Novartis Neutral | UBS AG | |
| 20.11.25 | ABB Neutral | UBS AG | |
| 19.11.25 | Zurich Insurance Verkaufen | DZ BANK |
Analysen zu Aktien folgender Indizes
ETF-Sparplan
Oskar ist der einfache und intelligente ETF-Sparplan. Er übernimmt die ETF-Auswahl, ist steuersmart, transparent und kostengünstig.